Trial NCT02077959

View at ClinicalTrials.gov 
Org. Study IDs: OSU-13128
Secondary IDs: NCI-2014-00385

Last trial update was posted on 2023-01-27

MeSH Interventions

Lenalidomide Pidilizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Pharmaceutical Companies decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID